Form 13-F position report

APTOSE BIOSCIENCES INC

Reported by HighMark Wealth Management LLC

APTO CUSIP 03835T309 Manager CIK 0001802451

Reported 0 shares, down 300 (100.0%) from the prior quarter.

Reported value -100.0%; share count -100.0% vs. the prior quarter.

Reduced
% of reported 13F value 0 This manager · Q1 2025
Shares 0 Quarter-end amount reported
Reported value $0 Fair value at quarter end
Consecutive quarters held 18 Through Q1 2025

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Reported position value by quarter
Date Holding Value
2021-12-31 6000
2022-03-31 0
2022-06-30 3000
2022-09-30 3000
2022-12-31 2619
2023-03-31 2890
2023-06-30 0
2023-06-30 1392
2023-09-30 840
2023-12-31 762
2024-03-31 498
2024-06-30 228
2024-09-30 123
2024-12-31 68
2025-03-31 0

Quarterly position history

How this manager's reported quarter-end position changed over time.

15 quarters
Quarterly reported position history for APTOSE BIOSCIENCES INC held by HighMark Wealth Management LLC.
Quarter Activity Shares Change % of reported 13F Reported value Filed Source filing
Q1 2025 Reduced 0 -300 (-100.0%) 0 $0 2025-04-24
Q4 2024 Unchanged 300 0 (0.0%) < 0.01% $68 2025-01-31
Q3 2024 Unchanged 300 0 (0.0%) < 0.01% $123 2024-10-17
Q2 2024 Unchanged 300 0 (0.0%) < 0.01% $228 2024-07-29
Q1 2024 Unchanged 300 0 (0.0%) < 0.01% $498 2024-04-29
Q4 2023 Unchanged 300 0 (0.0%) < 0.01% $762 2024-01-23
Q3 2023 Unchanged 300 0 (0.0%) < 0.01% $840 2023-10-18
Q2 2023 New 300 +300 (0.0%) < 0.01% $1,392 2023-07-26
Q2 2023 Reduced 0 -4,515 (-100.0%) 0 $0 2023-07-26
Q1 2023 Unchanged 4,515 0 (0.0%) < 0.01% $2,890 2023-04-21
Q4 2022 Unchanged 4,515 0 (0.0%) < 0.01% $2,619 2023-02-02
Q3 2022 Unchanged 4,515 0 (0.0%) < 0.01% $3,000 2022-10-21
Q2 2022 New 4,515 +4,515 (0.0%) < 0.01% $3,000 2022-07-19
Q1 2022 Reduced 0 -4,515 (-100.0%) 0 $0 2022-04-25
Q4 2021 New 4,515 +4,515 (0.0%) < 0.01% $6,000 2022-01-20
Five years are shown. A free account unlocks the complete reported history. Unlock full history

Who else reported the position

24 managers reported APTOSE BIOSCIENCES INC for Q1 2025.

Managers reporting APTOSE BIOSCIENCES INC in Q1 2025.
Manager Activity Shares Change % of reported 13F Reported value Tenure
Annandale Capital LLC Reduced 0 -26,666 0 $0 3 qtrs
HighMark Wealth Management LLC This report Reduced 0 -300 0 $0 8 qtrs
NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO Reduced 0 -133 0 $0 8 qtrs
CONCOURSE FINANCIAL GROUP SECURITIES INC Unchanged 0 0 0 $0 8 qtrs
US BANCORP DE Reduced 0 -2,020 0 $0 8 qtrs
WELLS FARGO & COMPANY MN Unchanged 0 0 0 $0 8 qtrs
FIL Ltd Reduced 0 -1 0 $0 2 qtrs
HRT FINANCIAL LP Reduced 0 -43,112 0 $0 2 qtrs
Sigma Planning Corp Reduced 0 -703,384 0 $0 7 qtrs
GROUP ONE TRADING L P Reduced 0 -115 0 $0 8 qtrs
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
March 31, 2025
Filed
April 24, 2025
Filing type
13F-HR
Position type
COM

Voting authority reported

No voting-authority amounts were reported for this position. Voting authority is not required for reported call options.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.